JPMorgan lowered the firm’s price target on IBM (IBM) to $283 from $317 and keeps a Neutral rating on the shares after the company completed its $11B acquisition of Confluent. JPMorgan views the early completion of the deal positively. The firm cites recent peer multiple compression for the target cut. JPMorgan views IBM’s risk/reward as balanced at current valuation levels.
Claim 55% Off TipRanks
Forget margin or options. Here's how the pros trade IBMPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBM:
- IBM and Nvidia (NVDA) Partner to Help Businesses Deploy AI at Scale
- DA Davidson technology analysts hold an analyst/industry conference call
- IBM completed its acquisition of Confluent
- Quantum Computing News: IBM and Quantinuum Push Hybrid Computing as Security Race Heats Up
- IBM Introduces Blueprint to Combine Quantum Computers with Traditional Supercomputers